U.S. move imperils effort to reduce weapons risk from Iranian reactor
Trump administration will no longer waive sanctions for project
Latest News
Read our COVID-19 research and news.
-
-
Shuttered natural history museums fight for survival amid COVID-19 ‘heartbreak’
But creative scientists vow recovery and move research, public programs online -
Yemen was facing the world’s worst humanitarian crisis. Then the coronavirus hit
United Nations says it needs billions in donor money as cases mount in a country ravaged by civil war and cholera -
Designer antibodies fight cancer by tethering immune cells to tumor cells
Bispecific antibodies that bind two or more targets are the latest immunotherapy to shine in clinical trials -
Podcast: A rare condition associated with coronavirus in children, and tracing glaciers by looking at the ocean floor
On this week’s show: Researchers race to understand Kawasaki-like syndrome in children that has been linked to coronavirus, and exploring “grounding lines” on the ocean floor to track Antarctica’s glaciers -
Can plasma from COVID-19 survivors help save others?
Small studies suggest transfusions with antibody-laden blood plasma may help patients fight the virus -
‘Got my fingers crossed.’ As ITER fusion project marks milestone, chief ponders pandemic impact
First major piece of huge machine installed -
No asteroids needed: ancient mass extinction tied to ozone loss, warming climate
Malformed spores suggest powerful storms drove ozone loss and led to sterilizing UV radiation -
These bacteria have adapted to life in your nose—and that may be good news
Microbes may shield you from allergies and disease -
Eye-catching advances in some AI fields are not real
When tuned up, old algorithms can match the abilities of their successors -
As India’s lockdown ends, exodus from cities risks spreading COVID-19 far and wide
States scramble to deal with millions of jobless migrant workers returning home -
Mysterious radio bursts reveal missing matter in cosmos
Enigmatic bursts of energy used to identify half of all normal matter -
European R&D review finds lagging high-tech performance despite major science investment
Report says scientific output is not translating into innovation -
Merck, one of Big Pharma’s biggest players, reveals its COVID-19 vaccine and therapy plans
Company bets on vaccines using live viruses and an experimental compound with a dark side -
Sick chinchillas languish at farms that supply U.S. researchers
USDA documents years of animal welfare violations at two farms -
Japan ends its COVID-19 state of emergency
The country’s COVID-19 countermeasures relied on voluntary social distancing and limited testing -
U.S. lawmakers unveil bold $100 billion plan to remake NSF
Agency would get a huge technology research arm and a new name -
Mysterious ancient rock art may have been made with beeswax
Miniature outlines of humans and other objects have puzzled archaeologists for decades -
Study tells ‘remarkable story’ about COVID-19’s deadly rampage through a South African hospital
Staff and medical equipment carried the virus from patient to patient and from ward to ward -
Court rules ‘Dueling Dinos’ belong to landowners, in a win for science
Spectacular fossils can’t be legally considered minerals -
Doubts greet $1.2 billion bet by United States on a coronavirus vaccine by October
Operation Warp Speed’s funding of AstraZeneca is intended to deliver a COVID-19 vaccine by October, although some call that timeline unrealistic -
They redesigned PubMed, a beloved website. It hasn’t gone over well
Unhappy researchers unleash torrent of complaints on social media -
Coronavirus antigen tests: quick and cheap, but too often wrong?
Tests that detect coronavirus proteins raise hopes of widespread daily screening -
How Sweden wasted a ‘rare opportunity’ to study coronavirus in schools
One of the few countries to keep primary schools open failed to collect data on children’s role in pandemic -
‘The house was on fire.’ Top Chinese virologist on how China and U.S. have met the pandemic
Shao Yiming leads the HIV program at China’s Center for Disease Control and Prevention
